ELRITERCEPT

UNII:	ZNC37E4KAK
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ELRITERCEPT
GSRS Full Record:	ZNC37E4KAK i

2727114-26-1
1-109-Activin receptor type IIA (human construct KER-050) fusion protein with peptide linker (GGG) fusion protein with immunoglobulin G1 [de-339-lysine] (human γ1-chain C-terminal fragment), dimer
ELRITERCEPT [USAN]
Elritercept
Elritercept [WHO-DD]
Human activin receptor type 2-A (activin receptor type IIA, ACTR-IIA) extracellular domain (ECD) fragment (1-109) engineered variant (F15>Y, 21KD22>LE, P31>R, Y33>E, D35>E, R40>L, F43>Y, K47>R, Q58>K, I65>F, 76KKDS79>TEEN, E81>Q) fused via the peptide linker 110GGG112 to a human immunoglobulin G1 heavy chain fragment C-terminal Fc fragment (113-338), [Homo sapiens IGHG1*01; hinge: 113-122 (EPKSC 112-113del); CH2: 123-232; CH3: 233-337; CHS: 338-338 (K339del)]; disulfide bridged dimer, produced in Chinese hamster ovary (CHO) cells, glycoform alfa
KER-050
KER-050 (ActRIIA/B-Fc)
KER050
elritercept [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ELRITERCEPT

Synonyms and Mappings

Resources